SEC Form 4 · accession 0001209191-15-054402
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Johnson
Director
Period of report
Jun 16, 2015
Accepted (ET)
Jun 17, 2015 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $44.39 | Jun 16, 2015 | A | 10,000 | A | — | Jun 16, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option shares shall vest as follow: 1/12th of the shares subject to such option shall vest each month after June 16, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date.